LONDON: Oxford’s Covid-19 vaccine candidate has a better immune response when using a two full dose regimen rather than a full dose followed by a half-dose booster dose, the university said Thursday. The candidate vaccine, which has been licensed to AstraZeneca, has published the results of an interim late-stage trial …
Read More »
LONDON: Oxford University’s Covid-19 candidate vaccine has a better immune response when using a two-full-dose regimen rather than a full dose followed by a half-dose booster, the university said Thursday, citing data from the first trials. The developers of the candidate vaccine, which has been licensed to the pharmaceutical company …
Read More »
LONDON: Oxford’s Covid-19 vaccine candidate has a better immune response when using a two full dose regimen rather than a full dose followed by a half-dose booster dose, the university said Thursday. The candidate vaccine, which has been licensed to AstraZeneca, has published the results of an interim late-stage trial …
Read More »
FRANKFURT: Moderna will charge governments between $ 25 and $ 37 per dose of its Covid-19 candidate vaccine, depending on the amount requested, Chief Executive Stephane Bancel told the German weekly Welt am Sonntag (WamS). “So our vaccine costs about the same as a flu shot, which is between $ …
Read More »
The Brihanmumbai Municipal Corporation (BMC) has completed the second phase of clinical trials for the Oxford-AstraZeneca Covid-19 vaccine. The civic body will soon begin testing for the third phase after the first group of volunteers completes 28 days from their first vaccination. 200 healthy volunteers participated in the second phase …
Read More »
MUMBAI / LONDON: The Serum Institute of India has suspended trials of AstraZeneca’s Covid-19 vaccine candidate until the British drugmaker restarts trials, Serum said on Thursday. “We are reviewing the situation and stopping the trials in India,” Serum said in a short statement. AstraZeneca said Tuesday that it had halted …
Read More »